BlueSpruce Investments’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,752
Closed -$498K 35
2025
Q1
$498K Sell
3,752
-2,395,074
-100% -$305M 0.01% 31
2024
Q4
$271M Hold
2,398,826
5.51% 10
2024
Q3
$273M Buy
+2,398,826
New +$263M 5.04% 13
2022
Q1
Sell
-2,879,361
Closed -$405M 15
2021
Q4
$405M Sell
2,879,361
-1,126,846
-28% -$144M 6.35% 8
2021
Q3
$473M Sell
4,006,207
-208,576
-5% -$25.6M 8.24% 7
2021
Q2
$489M Buy
4,214,783
+3,047,969
+261% +$355M 8.91% 6
2021
Q1
$140M Buy
+1,166,814
New +$138M 2.77% 14

Other funds holding ABT

BlueSpruce Investments's ABT Position: Q2 2025 in Review

BlueSpruce Investments sold out of Abbott (ABT) in Q2 2025, closing a stake of 3,752 shares — an estimated $498K sold.

BlueSpruce Investments first reported a position in ABT in Q1 2021 and held it in 7 quarters. The position peaked at $489M in Q2 2021. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • BlueSpruce Investments reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • BlueSpruce Investments sold 3,752 Abbott shares in Q2 2025, an estimated $498K.
  • BlueSpruce Investments first reported a position in Abbott in Q1 2021 and held it in 7 quarters.
  • BlueSpruce Investments's Abbott position peaked at $489M in Q2 2021.
  • 3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on BlueSpruce Investments's 13F filing for Q2 2025, filed 14 Aug 2025.